MATRIX PHARMACEUTICAL INC/DE
10-K, 2000-03-14
PHARMACEUTICAL PREPARATIONS
Previous: MATRIX PHARMACEUTICAL INC/DE, 10-K, 2000-03-14
Next: STRUCTURED ASSET MORTGAGE INVESTMENTS INC, 8-K, 2000-03-14

QuickLinks -- Click here to rapidly navigate through this document


EXHIBIT 23.1


CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

    We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-32213) pertaining to the 1988 Restricted Stock Plan and the 1991 Directors' Stock Option Plan of Matrix Pharmaceutical, Inc., of our report dated January 21, 2000, with respect to the consolidated financial statements of Matrix Pharmaceutical, Inc. included in the Annual Report (Form 10-K) for the year ended December 31, 1999.

Ernst & Young LLP    

Palo Alto, California
March 14, 2000



QuickLinks

CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission